Proceedings of the Texas A&M Medical Student Grand Rounds

Role of calcium in Huntington’s Disease

July 19, 2018 Dayton Hunn

Dayton Hunn

Introduction: Huntington’s Disease (HD) is an autosomal dominant inherited disease in the huntingtin gene characterized by choreiform movement, severe cognitive decline, and behavioral changes, marked by death within 15 years of symptom presentation[1]. Although this disease was first described in the late 19th century, both a cure and disease-altering treatments remain elusive. Furthermore, the precise cellular mechanism of neuronal death in the caudate and putamen, the hallmark of HD, seems just out of reach despite a prevalence of about 6 in 100,000 in the United States[2]. Genetically, HD is diagnosed by a repeat expansion in the Huntintin gene (Htt), with disease severity correlating to expansion size. In early animal models, it was noted that programmed defects in calcium signaling conferred an HD phenotype, suggesting a relationship between HD and calcium regulation[3],[4],[5]. Recent studies have evaluated the interactions of both htt and mutant huntintin (mHtt)[6], as well as mhtt’s role in intracellular transport[7], endoplasmic reticulum (ER) dysfunction[8], mitochondria/ER axis control[9], and peripheral effects of mHtt[10]. Methods: Tandem affinity purification was used to evaluate the interaction od mHtt and Htt, fluorescence and confocal microscopy, was used to investigate Htt’s role in intracellular transport, immunostaining was used to visualize ER and mitochondrial involvement, and patch-clamp was used to determine the effects of skeletal muscle. Results: mHtt was found to preferentially associate and active proteins involved with mitochondrial dysfunction, and RNA post-translational modification and transport. Pathologic increases in intracellular mHTT was found to interact at each step of the protein secretory pathway. These increases in mHTT also conferred ER dysfunction, activating apoptosis pathways. Lastly, mHtt was found to alter the physiological dynamics of skeletal muscle contraction in the periphery. Conclusion: Various studies7-11 have illustrated the role of mHtt and problems in calcium handling resulting in cell death, which is a hallmark of HD. Calcium modification and buffering systems could offer a novel approach to treating the symptoms or preventing the progression of HD in future populations.

  1. Mccolgan P, Tabrizi SJ. Huntingtons disease: a clinical review. European Journal of Neurology. 2017;25(1):24-34. doi:10.1111/ene.13413.
  2. Odeyemi OA. Incidence and prevalence of Vibrio parahaemolyticus in seafood: a systematic review and meta-analysis. SpringerPlus. 2016;5(1). doi:10.1186/s40064-016-2115-7.
  3. Hampton T. Huntington Disease Cause. Jama. 2007;297(21):2339.
  4. Bates GP, Dorsey R, Gusella JF, et al. Huntington disease. Nature Reviews Disease Primers. 2015:15005. doi:10.1038/nrdp.2015.5.
  5. Mario AD, Scarlatti C, Costiniti V, et al. Calcium Handling by Endoplasmic Reticulum and Mitochondria in a Cell Model of Huntington’s Disease. PLoS Currents. 2016. doi:10.1371/currents.hd.37fcb1c9a27503dc845594ee4a7316c3
  6. Ratovitski T, Chighladze E, Arbez N, et al. Huntingtin protein interactions altered by polyglutamine expansion as determined by quantitative proteomic analysis. Cell Cycle. 2012;11(10):2006-2021. doi:10.4161/cc.20423.
  7. Brandstaetter H, Kruppa AJ, Buss F. Huntingtin is required for ER-to-Golgi transport and for secretory vesicle fusion at the plasma membrane. Disease Models & Mechanisms. 2014;7(12):1335-1340. doi:10.1242/dmm.017368.
  8. Ueda M, Li S, Itoh M, et al. Polyglutamine expansion disturbs the endoplasmic reticulum formation, leading to caspase-7 activation through Bax. Biochemical and Biophysical Research Communications. 2014;443(4):1232-1238. doi:10.1016/j.bbrc.2013.12.114.
  9. Mario AD, Scarlatti C, Costiniti V, et al. Calcium Handling by Endoplasmic Reticulum and Mitochondria in a Cell Model of Huntington’s Disease. PLoS Currents. 2016. doi:10.1371/currents.hd.37fcb1c9a27503dc845594ee4a7316c3
  10. Braubach P, Orynbayev M, Andronache Z, et al. Altered Ca2 signaling in skeletal muscle fibers of the R6/2 mouse, a model of Huntington’s disease. The Journal of General Physiology. 2014;144(5):393-413. doi:10.1085/jgp.201411255

 

Neuroscience
Previous Post

Role of calcium in Huntington’s Disease

Next Post

The Use of HDAC4-MAP1S System in the Treatment of Huntington’s Disease

Scientific Editors

Steve A. Maxwell

Executive Editor
Tel: 979-436-0804
smaxwell@medicine.tamhsc.edu

Robin Fuchs-Young

Deputy Editor
Tel: 979-845-5109
fuchs-young@medicine.tamhsc.edu
Administrative Editor

Janis Chmiel

Tel: 979-436-0856
chmiel@medicine.tamhsc.edu
Editorial Office
Tel.: 979-845-2726
Fax: 979-847-9481
chmiel@medicine.tamhsc.edu
Archives
  • July 2026
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • May 2025
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • November 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • August 2022
  • June 2022
  • May 2022
  • August 2021
  • July 2021
  • April 2021
  • October 2020
  • August 2020
  • July 2020
  • August 2019
  • July 2019
  • February 2019
  • July 2018
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • January 2017
Proudly powered by WordPress | Theme: Fmi by Forrss.